Literature DB >> 14732707

Similarity of binding sites of human matrix metalloproteinases.

Viera Lukacova1, Yufen Zhang, Martin Mackov, Peter Baricic, Soumyendu Raha, Jorge A Calvo, Stefan Balaz.   

Abstract

Tissue components hydrolyzing matrix metalloproteinases (MMPs) exhibit a high sequence similarity (56-64% in catalytic domains) and yet a significant degree of functional specificity. The hexapeptide-binding sites of 24 known human MMPs were compared in terms of their force field interaction energies with five probes that are most frequently encountered in substrates and inhibitors. The probes moved along a grid enclosing partially flexible binding sites in rigid catalytic domains that were represented by published experimental structures and comparative models and new comparative models for nine most recently characterized MMPs. For individual MMPs, representative interaction energies were obtained as averages for all suitable experimental structures. Correlations of the representative energies for all MMP pairs were succinctly catalogued for individual probes, subsites, and correlation levels. Among the probes (neutral sp(3) carbon and sp(3) oxygen, positive sp(3) nitrogen and hydrogen, and negative carbonyl oxygen), the last probe is least distinctive. Similarities of subsites are decreasing as S1 ' > S2 > S3 ' > S1 approximately S3 > S2 '. Most interesting, occupancies of subsites in published structures of MMP-inhibitor complexes follow an almost parallel trend, alluding to overall low selectivity of known MMP inhibitors. Flexible subsite S1 ' that appears as the specificity pocket in rigid x-ray structures is actually very similar among individual MMPs. Several correlations indicated that MMPs 3, 8, and 12 have similar binding sites. Modeling results are corroborated with published experimental data on MMP inhibition and substrate specificities. The results provide numerous clues for development of specific inhibitors and substrates, as well as for selection of MMPs for testing that provides maximum information without redundant experiments.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14732707     DOI: 10.1074/jbc.M313474200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

Review 1.  Matrix metalloproteinase inhibitors: a critical appraisal of design principles and proposed therapeutic utility.

Authors:  György Dormán; Sándor Cseh; István Hajdú; László Barna; Dénes Kónya; Krisztina Kupai; László Kovács; Péter Ferdinandy
Journal:  Drugs       Date:  2010-05-28       Impact factor: 9.546

2.  QM/MM Studies of the Matrix Metalloproteinase 2 (MMP2) Inhibition Mechanism of (S)-SB-3CT and its Oxirane Analogue.

Authors:  Jia Zhou; Peng Tao; Jed F Fisher; Qicun Shi; Shahriar Mobashery; H Bernhard Schlegel
Journal:  J Chem Theory Comput       Date:  2010-11-09       Impact factor: 6.006

3.  Conformational variability of matrix metalloproteinases: beyond a single 3D structure.

Authors:  Ivano Bertini; Vito Calderone; Marta Cosenza; Marco Fragai; Yong-Min Lee; Claudio Luchinat; Stefano Mangani; Beatrice Terni; Paola Turano
Journal:  Proc Natl Acad Sci U S A       Date:  2005-04-04       Impact factor: 11.205

4.  A combination of docking, QM/MM methods, and MD simulation for binding affinity estimation of metalloprotein ligands.

Authors:  Akash Khandelwal; Viera Lukacova; Dogan Comez; Daniel M Kroll; Soumyendu Raha; Stefan Balaz
Journal:  J Med Chem       Date:  2005-08-25       Impact factor: 7.446

5.  Identification of new snake venom metalloproteinase inhibitors using compound screening and rational Peptide design.

Authors:  Fabián Villalta-Romero; Anna Gortat; Andrés E Herrera; Rebeca Arguedas; Javier Quesada; Robson Lopes de Melo; Juan J Calvete; Mavis Montero; Renato Murillo; Alexandra Rucavado; José María Gutiérrez; Enrique Pérez-Payá
Journal:  ACS Med Chem Lett       Date:  2012-06-14       Impact factor: 4.345

6.  A comparison of the binding sites of matrix metalloproteinases and tumor necrosis factor-alpha converting enzyme: implications for selectivity.

Authors:  Viera Lukacova; Yufen Zhang; Daniel M Kroll; Soumyendu Raha; Dogan Comez; Stefan Balaz
Journal:  J Med Chem       Date:  2005-04-07       Impact factor: 7.446

Review 7.  Matrix metalloproteinase inhibitors (MMPIs) from marine natural products: the current situation and future prospects.

Authors:  Chen Zhang; Se-Kwon Kim
Journal:  Mar Drugs       Date:  2009-03-31       Impact factor: 5.118

8.  Synthesis and evaluation of novel heterocyclic MMP inhibitors.

Authors:  Ryuji Hayashi; Xiaomin Jin; Gregory R Cook
Journal:  Bioorg Med Chem Lett       Date:  2007-10-17       Impact factor: 2.823

9.  Matrix metalloproteinase 2 inhibition: combined quantum mechanics and molecular mechanics studies of the inhibition mechanism of (4-phenoxyphenylsulfonyl)methylthiirane and its oxirane analogue.

Authors:  Peng Tao; Jed F Fisher; Qicun Shi; Thom Vreven; Shahriar Mobashery; H Bernhard Schlegel
Journal:  Biochemistry       Date:  2009-10-20       Impact factor: 3.162

10.  Zinc-binding groups modulate selective inhibition of MMPs.

Authors:  Arpita Agrawal; Diego Romero-Perez; Jennifer A Jacobsen; Francisco J Villarreal; Seth M Cohen
Journal:  ChemMedChem       Date:  2008-05       Impact factor: 3.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.